Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 10,481 | 12,702 | 11,337 | 11,885 | 2,674 |
Marketable Securities | N/A | N/A | N/A | N/A | 3,137 |
Receivables | 3,627 | 6,547 | 7,446 | 9,343 | 18,701 |
Other current assets | 0 | 0 | 0 | 1,000 | 0 |
TOTAL | $14,339 | $19,796 | $19,613 | $23,584 | $25,485 |
Non-Current Assets | |||||
PPE Net | 386 | 484 | 789 | 1,178 | 6,262 |
Intangibles | 2,349 | 2,349 | 2,349 | 2,349 | 3,277 |
Other Non-Current Assets | 66 | 113 | 53 | 88 | 309 |
TOTAL | $2,800 | $2,946 | $3,191 | $3,615 | $9,848 |
Total Assets | $17,139 | $22,741 | $22,804 | $27,199 | $35,333 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 2,092 | 2,081 | N/A | N/A | N/A |
Accounts payable and accrued liabilities | 1,128 | 1,697 | 1,446 | 3,128 | 1,934 |
Accrued Expenses | 3,183 | 2,329 | 2,655 | 3,035 | 11,532 |
Other current liabilities | 52 | N/A | N/A | N/A | N/A |
TOTAL | $6,796 | $7,488 | $4,615 | $6,164 | $13,466 |
Non-Current Liabilities | |||||
Long Term Debt | 730 | 1,704 | N/A | N/A | 17,427 |
Deferred Revenues | 342 | 1,382 | 514 | N/A | N/A |
aiOther Non-Current Liabilities | 2,277 | 1,875 | 2,336 | 8,825 | 1,288 |
TOTAL | $3,008 | $3,579 | $2,336 | $8,825 | $18,714 |
Total Liabilities | $9,804 | $11,068 | $6,952 | $14,988 | $32,181 |
Shareholders' Equity | |||||
Shares Outstanding, K | 178 | 161 | 161 | 154 | 95 |
Common Shares | 5 | 5 | 5 | 5 | 3 |
Retained earnings | -210,328 | -198,610 | -193,690 | -189,892 | -155,043 |
Other shareholders' equity | -219 | -217 | 1,011 | 1,251 | 1,188 |
TOTAL | $7,336 | $11,674 | $15,852 | $12,211 | $3,152 |
Total Liabilities And Equity | $17,139 | $22,741 | $22,804 | $27,199 | $35,333 |